New Sales Partnership for Turkey
April 7, 2021
ec5 and TAKIMYA have recently signed a sales partnership for Turkey in a virtual ceremony. Mr. Fatih Aycan, Managing Director of TAKIMYA, and his team can look back on a solid experience in Near Infrared Spectroscopy in chemical, pharmaceutical and many more industries. We are looking forward to our cooperation with TAKIMYA as with their [...]
April 7, 2021
MENLO PARK, California -- Synthego, the genome engineering company, today announced the launch of Eclipse™, a new high-throughput cell engineering platform designed to accelerate drug discovery and validation by providing highly predictable CRISPR-engineered cells at scale through the integration of engineering, bioinformatics, and proprietary science. The launch of this unique CRISPR-based platform is driving the company’s growing [...]
Lonza Celebrates 20th Anniversary of Nucleofector™ Cell Transfection Platform
April 7, 2021
2021 marks the 20th anniversary of Nucleofector™ Platform – the industry-leading non-viral cell transfection method The technology is highly regarded and widely used across the research community, with a range of applications from basic research through to cell and gene therapy The Nucleofector™ System offers a flexible, reliable approach to transfection, including for primary cells, [...]
Illumina Joins the International Wheat Genome Sequencing Consortium
April 7, 2021
EAU CLAIRE, Wis., US – Illumina, a global leader in DNA sequencing and array-based technologies is joining the International Wheat Genome Sequencing Consortium (IWGSC) as a sponsoring partner. The IWGSC is an international, collaborative consortium of wheat growers, plant scientists, and public and private breeders dedicated to the development of genomic resources for wheat scientists and breeders. These [...]
AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine Tests
April 7, 2021
SOUTH SAN FRANCISCO, Calif & BEIJING -- AcornMed Biotechnology Co., Ltd. (AcornMed), a precision medicine organization that specializes in the testing and analysis of solid and blood tumors, announced today that they will incorporate Twist Bioscience next generation sequencing (NGS) target enrichment and library preparation panels into AcornMed’s portfolio of tests designed to provide insight [...]
TetraScience and IDBS Partner to Connect Data in R&D
April 7, 2021
Boston, MA and Guildford, UK - TetraScience, the world’s first and only open R&D Data Cloud for scientific discovery, and IDBS, a leading R&D technology and solutions provider, announce a strategic partnership to integrate the IDBS E-Workbook™ and Tetra Data Platform into a common ecosystem to provide end-to-end R&D data automation. This partnership provides seamless connectivity [...]
April 7, 2021
SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, has signed an agreement enabling multiple academic laboratories at Stanford University to access Twist Bioscience’s innovative antibody discovery and optimization services as well as its unique “Library of [...]
DeepMatter collaborates further with the University of Nottingham
April 7, 2021
DigitalGlassware ® to be adopted by the University of Nottingham's School of Chemistry to support the development of machine learning models of sustainable chemistry DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, is delighted to be collaborating again with the University of Nottingham's School of Chemistry, providing access to the DigitalGlassware® platform to [...]
Newomics Announces Sales Team and New Kits
April 7, 2021
Newomics Inc., a biotechnology company developing and commercializing mass spectrometry solutions, today announced that it has established a North America Sales Team, and it is launching a new product to enhance the existing mass spectrometry workflows. Newomics continues its dedication to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. [...]
April 7, 2021
Funding will accelerate company growth and infrastructure expansion leading up to full commercial launch Vizgen, the life science company dedicated to advancing human health by visualizing single-cell spatial genomics information, has closed a $37 million Series B financing. The financing was co-led by Novalis LifeSciences LLC, and current investor Northpond Ventures. Also participating in the round were [...]

